Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 4 Results

Title
Intervention Indication Therapeutic Area Year Actions
Anifrolumab for moderately to severly active, autoantibody-positive systemic lupus erythematosus Anifrolumab (MEDI546) Systemic lupus erythematosus (SLE) Immunology , Nephrology 2020 View  |  Download
Baricitinib for systemic lupus erythematosus Baricitinib (LY3009104; Olumiant) Systemic lupus erythematosus (SLE) Immunology , Nephrology 2021 View  |  Download
Belimumab in combination with rituximab for systemic lupus erythematosus (SLE) Belimumab (Benlysta; Lymphostat-B) , Rituximab (MabThera; Rituxan; RG 105) Systemic lupus erythematosus (SLE) Immunology , Nephrology 2021 View  |  Download
Forigerimod plus Standard of Care for Systemic Lupus Erythematosus Forigerimod acitate (Lupuzor. IPP-201101; CEP-33457) Systemic lupus erythematosus (SLE) Immunology , Nephrology 2018 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications